Citigroup’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $26.7M | Buy |
|
|||||
2024
Q4 | $1.3M | Sell |
|
|||||
2024
Q3 | $1.14M | Sell |
|
|||||
2024
Q2 | $1.3M | Sell |
|
|||||
2024
Q1 | $1.86M | Sell |
|
|||||
2023
Q4 | $2.8M | Buy |
|
|||||
2023
Q3 | $523K | Sell |
|
|||||
2023
Q2 | $2.37M | Buy |
|
|||||
2023
Q1 | $624K | Buy |
|
|||||
2022
Q4 | $482K | Sell |
|
|||||
2022
Q3 | $499K | Sell |
|
|||||
2022
Q2 | $968K | Buy |
|
|||||
2022
Q1 | $969K | Sell |
|
|||||
2021
Q4 | $1.24M | Sell |
|
|||||
2021
Q3 | $2.5M | Buy |
|
|||||
2021
Q2 | $2.01M | Buy |
|
|||||
2021
Q1 | $1.13M | Sell |
|
|||||
2020
Q4 | $1.7M | Buy |
|
|||||
2020
Q3 | $293K | Sell |
|
|||||
2020
Q2 | $889K | Buy |
|
|||||
2020
Q1 | $409K | Buy |
|
|||||
2019
Q4 | $517K | Sell |
|
|||||
2019
Q3 | $117K | Sell |
|
|||||
2019
Q2 | $209K | Buy |
|
|||||
2019
Q1 | $183K | Sell |
|
|||||
2018
Q4 | $257K | Buy |
|
|||||
2018
Q3 | $409K | Buy |
|
|||||
2018
Q2 | $325K | Buy |
|
|||||
2018
Q1 | $371K | Buy |
|
|||||
2017
Q4 | $235K | Buy |
|
|||||
2017
Q3 | $192K | Sell |
|
|||||
2017
Q2 | $216K | Buy |
|
|||||
2017
Q1 | $213K | Sell |
|
|||||
2016
Q4 | $244K | Sell |
|
|||||
2016
Q3 | $434K | Buy |
|
|||||
2016
Q2 | $664K | Sell |
|
|||||
2016
Q1 | $1.05M | Buy |
|
|||||
2015
Q4 | $1.26M | Buy |
|
|||||
2015
Q3 | $596K | Buy |
|
|||||
2015
Q2 | $98K | Sell |
|
|||||
2015
Q1 | $74K | Sell |
|
|||||
2014
Q4 | $87K | Buy |
|
|||||
2014
Q3 | $8K | Buy |
|
|||||
2014
Q2 | $2K | Buy |
|